Si-Bone (SIBN) Short term Debt (2019 - 2022)

Si-Bone (SIBN) posted quarterly Short term Debt of $1.5 million for Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.

Si-Bone (SIBN) Short term Debt (2019 - 2022) Analysis & Trends

Si-Bone's Short term Debt history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.

In Q3 2022, Short term Debt changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2022 stood at $1.5 million (changed N/A YoY), while the FY2019 annual figure was $4.4 million, changed N/A from the prior year.
Short term Debt for Q3 2022 stood at $1.5 million, down from $8.7 million in the prior quarter.
The five-year high for Short term Debt was $8.7 million in Q1 2020, with the low at $1.5 million in Q3 2022.
The 3-year median for Short term Debt is $4.4 million (2019), against an average of $4.8 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Si-Bone	868.19 Mn	722.25 Mn	44.55 Mn

Download Data